Cargando…

Efficacy of tolvaptan on the short and mid-term prognosis in elderly patients with acute heart failure coexisting with oliguria: A retrospective cohort study

BACKGROUND: In patients with acute heart failure (AHF) coexisting with oliguria, high doses of loop diuretics are often ineffective in increasing urine output and may adversely affect the patient's prognosis, especially in elderly patients. We investigated the efficacy of adding tolvaptan (TLV)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Zhang, Yabin, Chen, Hongyu, Zhao, Jiahui, Ma, Qiang, Yang, Guang, Wang, Xiaohua, Wu, Zhen, Hou, Jiebin, Cheng, Qingli, Ao, Qiangguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868427/ https://www.ncbi.nlm.nih.gov/pubmed/36698930 http://dx.doi.org/10.3389/fcvm.2022.1075631

Ejemplares similares

Association of serum N-terminal pro-brain natriuretic peptide levels with survival and renal outcomes among elderly patients with acute kidney injury in chronic heart failure
por: Hou, Jiebin, et al.
Publicado: (2023)

Survival outcomes in older patients with different stages of acute kidney injury defined by the addition of urine output criteria
por: Hou, Jiebin, et al.
Publicado: (2023)

Impact of Diabetes on the Recurrence and Prognosis of Acute Kidney Injury in Older Male Patients: A 10-Year Retrospective Cohort Study
por: Shen, Xin, et al.
Publicado: (2022)

A woman with ascites and oliguria
por: Zeier, M. G., et al.
Publicado: (2013)

Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials
por: Ma, Guang, et al.
Publicado: (2019)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

Oliguria in critically ill patients: a narrative review
por: Klein, Sebastian J., et al.
Publicado: (2018)

Neutrophil gelatinase-associated lipocalin in ICU patients developing oliguria
por: Roman, A, et al.
Publicado: (2011)

Transient Oliguria during Anesthesia in Cerebral Salt Wasting Syndrome
por: Lee, Kwang Ho, et al.
Publicado: (2016)

The Cushing Reflex: Oliguria as a Reflection of an Elevated Intracranial Pressure
por: Leyssens, K., et al.
Publicado: (2017)

Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment
por: Jung, Sung-Hoon, et al.
Publicado: (2015)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Oliguria as predictive biomarker of acute kidney injury in critically ill patients
por: Prowle, John R, et al.
Publicado: (2011)

Perioperative oliguria: adequate physiological response or risk for acute kidney injury?
por: Mendes, Renata de Souza, et al.
Publicado: (2021)

A man with severe SARS-CoV-2 pneumonia and oliguria
por: Manzur-Sandoval, Daniel, et al.
Publicado: (2022)

Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan
por: Fujioka, Kensuke, et al.
Publicado: (2019)

Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort study
por: Samim, Daryoush, et al.
Publicado: (2023)

Renal resistive index can predict response to furosemide in septic patients with oliguria
por: Gornik, I, et al.
Publicado: (2013)

The Role of Oliguria and the Absence of Fluid Administration and Balance Information in Illness Severity Scores
por: Glassford, Neil J., et al.
Publicado: (2017)

Oliguria on the Day of Intubation Is Associated With Mortality in Patients With Acute Respiratory Distress Syndrome
por: Fadel, Raef A., et al.
Publicado: (2022)

Identification of an optimal threshold to define oliguria in critically ill patients: an observational study
por: Bianchi, Nathan Axel, et al.
Publicado: (2023)

Tolvaptan should be used very carefully in very elderly patients
por: Kahraman, Fatih, et al.
Publicado: (2018)

Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022)

The clinical relevance of oliguria in the critically ill patient: analysis of a large observational database
por: Vincent, Jean-Louis, et al.
Publicado: (2020)

COVID-19 and Kidney Involvement – A Systematic Review
por: Yang, Guang, et al.
Publicado: (2021)

Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan
por: Kobayashi, Masakazu, et al.
Publicado: (2023)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Preoperative Liver Function Test Abnormalities Were Associated With Short-Term and Long-Term Prognosis in Cardiac Surgery Patients Without Liver Disease
por: Shang, Liqun, et al.
Publicado: (2021)

Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis
por: Wan, Yan-di, et al.
Publicado: (2022)

Integrating network pharmacology and experimental verification to explore the mechanism of puerarin against oliguria in acute alcoholism
por: Wan, Mei-Xuan, et al.
Publicado: (2022)

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
por: Kiuchi, Shunsuke, et al.
Publicado: (2021)

Association of Oliguria With Acute Kidney Injury Diagnosis, Severity Assessment, and Mortality Among Patients With Critical Illness
por: Bianchi, Nathan Axel, et al.
Publicado: (2021)

Tolvaptan-induced isolated elevation of bilirubin in a patient with Gilbert syndrome
por: Nguyen, Matthew, et al.
Publicado: (2023)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

T cell immunoglobulin and mucin domain-containing protein 3 is highly expressed in patients with acute decompensated heart failure and predicts mid-term prognosis
por: Meng, Xin, et al.
Publicado: (2022)

A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure
por: Zhang, Zhi-gang, et al.
Publicado: (2018)

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
por: Suzuki, Satoshi, et al.
Publicado: (2014)

An elderly female case of AQP4 and GFAP double-positive NMOSD coexisting with ovarian teratoma
por: Yang, Jiahui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ih09oaes388cs8f2qmsf2j1e9r